AKT1 and melanoma: The RAF–MEK–ERK and PI3K–AKT signaling pathways are key players in melanoma progression and drug resistance.13,14 Preclinical studies have implicated a fundamental role of the PI3K–AKT signaling pathway in both metastatic spread to the brain and survival and growth of melanoma cells in the brain microenvironment.